Nomowake 25 25 mg Tablet

Nomowake 25 25 mg Tablet

S2
PDF Leaflet Revision Date: 8 November 2022


Clinical Summary

Quick overview from the medicine insert

Indication

Alleviation of insomnia.

Dosage (summary)

1-2 tablets at bedtime for adults over 12 years.

Onset of Action / Duration

Onset: 30 mins, Duration: 6-8 hours

Special Populations

  • Elderly patients
  • Hepatic impairment
  • Renal impairment

Pregnancy & Breastfeeding

Contraindicated in pregnancy and breastfeeding.

Key Drug Interactions

  • CNS depressants
  • MAOIs
  • QT prolonging medications

Contraindications

  • Hypersensitivity to doxylamine
  • Severe cardiovascular disorders
  • Epilepsy
  • Acute asthma attack

Common side effects

  • Drowsiness
  • Dry mouth
  • Constipation
  • Blurred vision
  • Urinary retention

Counselling Points

  • Avoid alcohol during treatment
  • Do not operate machinery if drowsy
  • Consult doctor if insomnia persists

Serious warnings

  • Short treatment duration recommended
  • Caution in elderly patients
  • Risk of falls in elderly

Only Available on the App

To ensure the fastest, most secure experience, this feature is exclusively available on the free Medinsert mobile app.

Download the App. Its Free!
On This Page
Nomowake 25 25 mg Tablet
1/-
Loading package insert…

Medinsert AI

Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
App Icon

Medinsert Mobile App

3000+ Package Inserts on the go.

VIEW